8-K: Cross Country Healthcare Q1 2026 Results Show Sequential Revenue Growth

Cross Country Healthcare announced first quarter 2026 financial results, reporting a net loss but highlighting sequential revenue growth and strategic wins.

Summary

• Cross Country Healthcare reported first quarter 2026 revenue of $241.1 million, an 18% decrease year-over-year but a 2% increase sequentially.
• The company experienced a net loss attributable to common stockholders of $4.3 million, or $0.14 per diluted share.
• Adjusted EBITDA was $3.9 million, a decrease of 55% year-over-year but relatively stable sequentially.
• Nurse and Allied Staffing revenue was $201.4 million, down 17% year-over-year but up 4% sequentially.
• Physician Staffing revenue was $39.6 million, down 23% year-over-year and 7% sequentially.
• The company generated $4.8 million in cash flow from operations.
• Cross Country Healthcare repurchased approximately 0.7 million shares for $5.8 million during the quarter.
• The company ended the quarter with $105.6 million in cash and no debt.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a cautiously neutral to slightly negative sentiment, primarily due to the significant year-over-year declines in revenue and profitability, despite positive sequential trends and strategic wins.

Positives

• Sequential revenue growth of 2% to $241.1 million.
• Travel Nurse and Allied segments grew 7% sequentially.
• Cross Country Community Care showed 16% year-over-year revenue growth.
• Signed 4 new MSP/VMS agreements.
• Licensed Intellify platform to a top ten healthcare staffing provider.
• Repurchased over 650,000 shares (2.1% of outstanding shares).
• Ended the quarter with $105.6 million in cash and no debt.
• Positive cash flow from operations of $4.8 million.

Negatives

• Net loss attributable to common stockholders of $4.3 million ($0.14 diluted EPS).
• Revenue decreased 18% year-over-year.
• Consolidated gross profit margin decreased 30 basis points year-over-year to 19.7%.
• Adjusted EBITDA decreased 55% year-over-year to $3.9 million.
• Adjusted EBITDA margin decreased 130 basis points year-over-year to 1.6%.
• Nurse and Allied Staffing revenue decreased 17% year-over-year.
• Physician Staffing revenue decreased 23% year-over-year.
• Cash flow from operations decreased 16% year-over-year.

Risks

• The timing to consummate the proposed Merger with Knox Lane.
• Risk that a condition of closing of the proposed Merger may not be satisfied or that the closing may not occur.
• Risk that regulatory approval for the proposed Merger is not obtained or is obtained subject to unanticipated conditions.
• Diversion of management time on transaction-related issues and disruption of ongoing business operations.
• Adverse effects on the market price of the Company's common stock due to the Merger announcement.
• Adverse effect on the ability to retain customers, key personnel, and maintain relationships with suppliers and customers.
• Occurrence of any event, change, or other circumstance that could give rise to the termination of the Merger Agreement.
• Worldwide economic or political changes affecting the markets served by the Company's businesses.

Future Outlook

The company's focus remains on disciplined execution and advancing technology initiatives while awaiting the closing of the pending transaction with Knox Lane in the third quarter.

Management Comments

• "We ended the first quarter with positive momentum, underscored by sequential revenue growth and several new MSP wins and expansions," said Kevin C. Clark, Co-Founder, Chairman and Chief Executive Officer.
• "As we await the closing of the pending transaction with Knox Lane in the third quarter, our focus remains on disciplined execution and advancing our technology initiatives to support our clients evolving workforce needs."

Industry Context

StockSavvy.ai notes that Cross Country Healthcare's results reflect ongoing pressures in the healthcare staffing market, with year-over-year declines in revenue and profitability. However, sequential improvements and strategic wins like the Intellify licensing suggest efforts to adapt and innovate within a competitive landscape.

Comparison to Industry Standards

• No specific industry benchmarks or competitor comparisons were provided in the filing.
• The filing does not offer direct comparisons to global benchmarks or specific comparable companies.

Stakeholder Impact

• Shareholders: The pending merger with Knox Lane may lead to delisting from Nasdaq and deregistration under the Exchange Act, impacting liquidity and public market access. Share repurchases may benefit existing shareholders.
• Employees: Potential disruption of management time and retention of key personnel due to the merger.
• Customers: Potential impact on customer relationships and service delivery due to the merger.
• Suppliers: Potential impact on relationships with suppliers due to the merger.

Next Steps

• Await the closing of the pending transaction with Knox Lane in the third quarter.
• Continue to focus on disciplined execution.
• Advance technology initiatives to support client workforce needs.

Key Dates

Recommendation

The company shows signs of sequential improvement and strategic progress, but the significant year-over-year declines and the uncertainty surrounding the pending merger warrant a cautious 'hold' rating. Investors should monitor the merger's progress and the company's ability to return to year-over-year growth.

Keywords

Cross Country Healthcare, Healthcare Staffing, Nurse Staffing, Allied Health Staffing, Physician Staffing, Financial Results, 8-K Filing, Intellify